Clinical Trials

Infantile Hemangioma

Posted on 1/2/2019
This study is being conducted in infants with one or more hemangiomas (hemangioma is a birthmark that most commonly appears as a rubbery, bright red nodule of extra blood vessels in the skin.)  The purpose of the study is to assess the effectiveness of 2 different strengths of the study medication which is applied directly on the hemangioma.

Your child may qualify if:
  • Your child is 0-84 days of age
  • You are the parent or have documentation of legal guardianship
  • Your child's hemangioma has not been previously treated with any other type of drug or laser therapy

Your child's participation in the study will last up to 270 days with 7 visits to the clinic and 2 phone contacts.  You will be compensated for your time and travel up to $350 for your child's participation in the study. 

Call our office for more information - (903) 238-8854
What Our Research Patients are Saying
"Last January I had to begin taking insulin for my diabetes. It was life changing for me. I had always been afraid of starting insulin. However, when I qualified for the diabetes clinical trial, it helped me accept this change in my life. The Research Coordinators are the very best you could ask for. They explained everything and let me know what to expect. I could never have controlled my diabetes if it hadn't been for this research program, the research staff and the study doctor. I would recommend participating in a research trial to anyone who has diabetes. It and the research staff are a godsend."
~ C.D

Contact Form

DCOL of Longview